Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 1/20 | 0.36 |
| ▸ | GABRG2 | P18507 | 5/20 | 0.34 |
| ▸ | GABRB3 | P28472 | 5/20 | 0.34 |
| ▸ | GABRA5 | P31644 | 5/20 | 0.34 |
| ▸ | GABRA3 | P34903 | 5/20 | 0.34 |
| ▸ | PIK3R2 | O00459 | 1/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.33 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.32 |
| ▸ | PIM1 | P11309 | 1/20 | 0.32 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | GRM5 | P41594 | 3/20 | 0.31 |
| ▸ | MYC | P01106 | 1/20 | 0.31 |
| ▸ | FLT3 | P36888 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22158385 | 0.97 | TGFBR1 (0.38) | TGFBR1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL22158387 | 0.94 | TGFBR1 (0.36) | TGFBR1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL22156459 | 0.91 | TGFBR1 (0.37) | TGFBR1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL22158380 | 0.89 | PGR (0.36) | GABRG2GABRB3GABRA5GABRA3ALDH1A3 | |
| SCHEMBL22156429 | 0.89 | SLC6A9 (0.35) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| SCHEMBL22156660 | 0.89 | PGR (0.37) | TGFBR1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL22156448 | 0.88 | TGFBR1 (0.39) | TGFBR1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL21898539 | 0.88 | TGFBR1 (0.35) | TGFBR1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL22156896 | 0.87 | CYP11B1 (0.38) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| SCHEMBL22156823 | 0.85 | PGR (0.38) | GABRG2GABRB3GABRA5GABRA3ALDH1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200203628-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200203628-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, ORC3, OR51E2 | TGFBR1 2276/4885GABRG2 2454/4885GABRB3 1289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.